HHG & Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$737K Sell
10,234
-495
-5% -$37.5K 0.2% 102
2015
Q4
$904K Sell
10,729
-105
-1% -$8.71K 0.24% 99
2015
Q3
$907K Sell
10,834
-75
-0.7% -$6.33K 0.28% 96
2015
Q2
$911K Sell
10,909
-10,506
-49% -$801K 0.26% 100
2015
Q1
$1.56M Sell
21,415
-806
-4% -$57.4K 0.41% 72
2014
Q4
$1.53M Buy
22,221
+707
+3% +$47.7K 0.37% 74
2014
Q3
$1.4M Sell
21,514
-110
-0.5% -$6.96K 0.46% 63
2014
Q2
$1.35M Sell
21,624
-25
-0.1% -$1.49K 0.44% 79
2014
Q1
$1.27M Buy
21,649
+210
+1% +$11.7K 0.44% 81
2013
Q4
$1.09M Hold
21,439
0.4% 87
2013
Q3
$1.08M Sell
21,439
-95
-0.4% -$4.97K 0.44% 82
2013
Q2
$1.06M Buy
+21,534
New +$1.17M 0.43% 82

Other funds holding LLY

HHG & Company's LLY Position: Q1 2016 in Review

HHG & Company reduced its Eli Lilly (LLY) stake by 4.6% in Q1 2016, selling an estimated $37.5K and leaving 10,234 shares worth $737K. The position accounts for 0.2% of the portfolio, ranked #102.

HHG & Company first reported a position in LLY in Q2 2013 and has held it in 12 quarters since. The position peaked at $1.56M in Q1 2015. 1,152 funds tracked by Wall St. Rank hold LLY as of Q1 2016.

  • HHG & Company held 10,234 shares of Eli Lilly worth $737K as of Q1 2016.
  • HHG & Company sold 495 Eli Lilly shares in Q1 2016, an estimated $37.5K.
  • Eli Lilly made up 0.2% of HHG & Company's portfolio in Q1 2016, its #102 holding.
  • HHG & Company first reported a position in Eli Lilly in Q2 2013 and has held it in 12 quarters since.
  • HHG & Company's Eli Lilly position peaked at $1.56M in Q1 2015.
  • 1,152 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2016.

Based on HHG & Company's 13F filing for Q1 2016, filed 20 Apr 2016.